Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The impact of restricted gestational weight gain by dietary intervention on fetal growth in women with gestational diabetes mellitus

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Mono- and co-activation of the GIP and GLP-1 receptors inhibits bone resorption

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • Joachim Gæde
  • Jens Oellgaard
  • Rikke Ibsen
  • Peter Gæde
  • Emil Nørtoft
  • Hans-Henrik Parving
  • Jakob Kjellberg
  • Oluf Pedersen
View graph of relations

AIMS/HYPOTHESIS: Long-term follow-up of the Steno-2 study demonstrated that intensified multifactorial intervention increased median lifespan by 7.9 years and delayed incident cardiovascular disease by a median of 8.1 years compared with conventional multifactorial intervention during 21.2 years of follow-up. In this post hoc analysis of data from the Steno-2 study, we aimed to study the difference in direct medical costs associated with conventional vs intensified treatment.

METHODS: In 1993, 160 Danish individuals with type 2 diabetes and microalbuminuria were randomised to conventional or intensified multifactorial target-driven intervention for 7.8 years. Information on direct healthcare costs was retrieved from health registries, and the costs in the two groups of participants were compared by bootstrap t test analysis.

RESULTS: Over 21.2 years of follow-up, there was no difference in total direct medical costs between the intensified treatment group, €12,126,900, and the conventional treatment group, €11,181,700 (p = 0.48). The mean cost per person-year during 1996-2014 was significantly lower in the intensified treatment group (€8725 in the intensive group and €10,091 in the conventional group, p = 0.045). The main driver of this difference was reduced costs associated with inpatient admissions related to cardiovascular disease (p = 0.0024).

CONCLUSIONS/INTERPRETATION: Over a follow-up period of 21.2 years, we found no difference in total costs and reduced cost per person-year associated with intensified multifactorial treatment for 7.8 years compared with conventional multifactorial treatment. Considering the substantial gain in life-years and health benefits achieved with intensified treatment, we conclude that intensified multifaceted intervention in high-risk individuals with type 2 diabetes seems to be highly feasible when balancing healthcare costs and treatment benefits in a Danish healthcare setting.

Original languageEnglish
JournalDiabetologia
Volume62
Issue number1
Pages (from-to)147-155
Number of pages9
ISSN0012-186X
DOIs
Publication statusPublished - 1 Jan 2019

    Research areas

  • Health economy, Multifactorial intervention, Organ complications, Type 2 diabetes

ID: 55400152